Pharmacology II Dentistry 1

download Pharmacology II Dentistry 1

of 59

Transcript of Pharmacology II Dentistry 1

  • 8/2/2019 Pharmacology II Dentistry 1

    1/59

    PHARMACOLOGY II DENTISTRY

    GENERAL & LOCAL ANESTHESIA

    Dr Mohammed Shamssain

  • 8/2/2019 Pharmacology II Dentistry 1

    2/59

    Course Contents

    General & local anesthetics

    Sedative hypnotics & pharmacology of

    alcoholism

    Treatment of epilepsy & parkinsonism

    Antipsychotics, anti depressant & anxiolytics

    Pharmacology of pain Adrenal cortex hormones & steroidal anti-

    inflammatory drugs

  • 8/2/2019 Pharmacology II Dentistry 1

    3/59

    Course Contents

    Thyroid hormones & anti-thyroid drugs

    Calcium metabolism

    Gonadal hormones & their antagonists

    Oral contraceptives

    Pharmacology of diabetes mellitus

    Antimicrobial agents

    Antifungal & antiviral agents

    Treatment of cancer & parasitic infestation

  • 8/2/2019 Pharmacology II Dentistry 1

    4/59

    Assessment

    Quiz one: one hour; 20%; date: Monday 19th

    March (1-2 pm)

    Mid-term exam: one hour; 20%

    Quiz two: one hour; 20%; date: Monday 14th

    May (1-2 pm)

    Final exam: two hours; 40%

  • 8/2/2019 Pharmacology II Dentistry 1

    5/59

    General

    Noradrenaline: noradrenergic transmission is important in

    control of mood (functional deficiency resulting

    depression)

    controlling wakefulness, and alertness Dopamine: is important in

    motor control (parkinsonism is due to dopamine

    deficiency)

    has behavioural effects (excessive dopamine activity isimplicated in schizophrenia)

    hormone release (prolactin, GH)

    dopamine in chemoreceptor trigger zone causes nausea

    & vomiting

  • 8/2/2019 Pharmacology II Dentistry 1

    6/59

    General

    5-HT: physiological functions associated with 5-HTpathways include: feeding behaviour, behaviouralresponse, control of mood and emotion, control ofbody temperature and vomiting

    Ach: has effects on arousal, on learning, and on shortterm memory. Dementia and parkinsonism areassociated with abnormalities in cholinergicpathways.

    GABA (Gamma-AminoButyric Acid): is an inhibitoryNT in CNS

    Glycine: an inhibitory NT , acts on GABA like receptorin spinal cord

  • 8/2/2019 Pharmacology II Dentistry 1

    7/59

    Anesthetics

  • 8/2/2019 Pharmacology II Dentistry 1

    8/59

    Ion Channels

  • 8/2/2019 Pharmacology II Dentistry 1

    9/59

    Synapse

  • 8/2/2019 Pharmacology II Dentistry 1

    10/59

    AnestheticSuppression ofPhysiologicalResponse to

    Surgery

  • 8/2/2019 Pharmacology II Dentistry 1

    11/59

    Essential Components of Anesthesia

    Analgesia- perception of pain eliminated

    Hypnosis- unconsciousness Depression of spinal motor reflexes

    Muscle relaxation

    * These terms together emphasize the role ofimmobility and of insensibility!

  • 8/2/2019 Pharmacology II Dentistry 1

    12/59

    Stages of Anesthesia

    In general anesthesia: the patient is

    unconscious and has no awareness or othersensations.

    The relationship between the amount ofgeneral anesthetic administered and the

    depression of the brain's sensory usefullydivided into stages to describe the depth ofanesthesia.1,3,5

  • 8/2/2019 Pharmacology II Dentistry 1

    13/59

    Mechanism of Action

    General Anesthetics CNS modifyingfunctions of ION CHANNELSmodifying theelectrical activity of neurons at a molecular level

    This may occur by anesthetic molecules binding directly to ion channels or

    by their disrupting the functions of molecules thatmaintain ion channels.

    a general anesthetic is a drug that has the abilityto bring about a reversible loss of consciousness by act on CNS via shutting off the brain from external

    stimuli

  • 8/2/2019 Pharmacology II Dentistry 1

    14/59

    Anesthetics divide into 2 classes:

    InhalationAnesthetics

    Gasses or Vapors

    Usually Halogenated

    IntravenousAnesthetics

    Injections

    Anesthetics or inductionagents

  • 8/2/2019 Pharmacology II Dentistry 1

    15/59

  • 8/2/2019 Pharmacology II Dentistry 1

    16/59

    What are General Anesthetics?

    A drug that brings about a reversible loss of

    consciousness. Administered by an anesthesiologist in order

    to induce or maintain general anesthesia tofacilitate surgery.

  • 8/2/2019 Pharmacology II Dentistry 1

    17/59

    Pathway for General Anesthetics

  • 8/2/2019 Pharmacology II Dentistry 1

    18/59

    Pathway for General Anesthetics

    Partial Pressure in brain quickly equilibrates

    with partial pressure in arterial blood whichhas equilibrated with partial pressureperfused alveoli.

    DEPTH of anesthesia induced by an inhaled

    anesthetic depends primarily on thePARTIAL PRESSURE!!! Of the anestheticsin the brain

  • 8/2/2019 Pharmacology II Dentistry 1

    19/59

    Pathway of General Anesthetics

    Rate of induction and recovery from

    anesthesia depends on the rate of change ofpartial pressure in the brain.

    These drugs are small lipid-solublemolecules that cross the alveolar membrane

    easily. Move into and out of the blood basedon the partial pressure gradient.

  • 8/2/2019 Pharmacology II Dentistry 1

    20/59

    Variables that Control Partial Pressure

    in Brain

    Direct Physician's Control Solubility of agent

    Concentration of agent in inspired by air

    Magnitude of alveolar ventilation

    Indirect Physicians Control Pulmonary blood flow-function of CO

    Arteriovenous concentration gradient

  • 8/2/2019 Pharmacology II Dentistry 1

    21/59

    Rate of Entry into the Brain: Influence

    of Blood and Lipid Solubility

  • 8/2/2019 Pharmacology II Dentistry 1

    22/59

    Rate of Entry into the Brain

    LOW solubility in blood= fast induction and

    recovery HIGH solubility in blood= slower induction

    and recovery.

  • 8/2/2019 Pharmacology II Dentistry 1

    23/59

    General Anesthetics

  • 8/2/2019 Pharmacology II Dentistry 1

    24/59

    General Anesthetics

  • 8/2/2019 Pharmacology II Dentistry 1

    25/59

    General Actions of Inhaled Anesthetics

    Respiration

    Depressed respiration and response to CO2 Kidney

    Depression of renal blood flow and urine output

    Muscle

    High enough concentrations will relax skeletalmuscle

  • 8/2/2019 Pharmacology II Dentistry 1

    26/59

    Cont

    Cardiovascular System

    Generalized reduction in arterial pressure andperipheral vascular resistance. Isofluranemaintains CO and coronary function better thanother agents

    Central Nervous System Increased cerebral blood flow and decreased

    cerebral metabolism

  • 8/2/2019 Pharmacology II Dentistry 1

    27/59

    Inhaled Anesthetics

  • 8/2/2019 Pharmacology II Dentistry 1

    28/59

    Inhaled Anesthetics

    Halothane

    Enflurane

    Isoflurane

    Desflurane

    Halogenatedcompounds:

    ContainFluorineand/orbromideSimple, small

    molecules

  • 8/2/2019 Pharmacology II Dentistry 1

    29/59

    Injectable Anesthetics

  • 8/2/2019 Pharmacology II Dentistry 1

    30/59

    Intravenous Anesthetics

    Used in combinationwith Inhaled

    anesthetics to: Supplement general

    anesthesia

    Maintain generalanesthesia

    Provide sedation

    Control blood pressure

    Protect the brain

  • 8/2/2019 Pharmacology II Dentistry 1

    31/59

    Adjunct Agents

  • 8/2/2019 Pharmacology II Dentistry 1

    32/59

    Anticholinergic Drugs

    Block the effects of Ach and other cholinergic

    drugs at cholinergic receptors of effector cells

    Two major types

    Antinicotinics include ganglion blockers and

    neuromuscular blockers

    Anti muscarinics include tertiary amines (e.g:

    atropine , scopolamine, etc)

  • 8/2/2019 Pharmacology II Dentistry 1

    33/59

    Mechanism of Action of Anesthesia

  • 8/2/2019 Pharmacology II Dentistry 1

    34/59

    MAC:Minimum Alveolar Conc

    MAC is a concept used to compare the

    strengths, or potency, of anaesthetic vapours

    Defined as the concentration of the vapour in

    the lungs that is needed to prevent movement

    (motor response) in 50% of subjects in response

    to surgical (pain) stimulus.

    A lower MAC value represents a more potent

    volatile anesthetic.

  • 8/2/2019 Pharmacology II Dentistry 1

    35/59

    Overton Meyer Theory

    O-M Theory: The MAC of a volatile substance isinversely proportional to its lipid solubility (oil:gascoefficient)

    MAC is inversely related to potency i.e. high macequals low potency.

    The hypothesis correlates lipid solubility of ananaesthetic agent with potency (1/MAC)

    Onset of anaesthesia occurs when sufficientmolecules of the anaesthetic agent havedissolved in the cell's lipid membranes, resultingin anaesthesia

  • 8/2/2019 Pharmacology II Dentistry 1

    36/59

    Indications

  • 8/2/2019 Pharmacology II Dentistry 1

    37/59

    Side Effects

  • 8/2/2019 Pharmacology II Dentistry 1

    38/59

    Local Anesthetics

  • 8/2/2019 Pharmacology II Dentistry 1

    39/59

    Types of Local Anesthetics

  • 8/2/2019 Pharmacology II Dentistry 1

    40/59

  • 8/2/2019 Pharmacology II Dentistry 1

    41/59

    Parenteral Anesthetic Agents

  • 8/2/2019 Pharmacology II Dentistry 1

    42/59

    Drug Effects

  • 8/2/2019 Pharmacology II Dentistry 1

    43/59

    Indications

  • 8/2/2019 Pharmacology II Dentistry 1

    44/59

  • 8/2/2019 Pharmacology II Dentistry 1

    45/59

    Side Effects

  • 8/2/2019 Pharmacology II Dentistry 1

    46/59

    Neuromuscular Blocking Agents

  • 8/2/2019 Pharmacology II Dentistry 1

    47/59

    NMBAs

  • 8/2/2019 Pharmacology II Dentistry 1

    48/59

    NMBAs:Depolarizing Agents

  • 8/2/2019 Pharmacology II Dentistry 1

    49/59

    NMBAs:Non-Depolarizing Agents

  • 8/2/2019 Pharmacology II Dentistry 1

    50/59

    NMBAs

  • 8/2/2019 Pharmacology II Dentistry 1

    51/59

    NMBAs:Indications

  • 8/2/2019 Pharmacology II Dentistry 1

    52/59

    NMBAs: Side Effects

  • 8/2/2019 Pharmacology II Dentistry 1

    53/59

    NMBAs: Overdose

  • 8/2/2019 Pharmacology II Dentistry 1

    54/59

    Depression of respiratory drive

    Decreased CO2 drive (medullary chemoreceptors),

    Takes MORE CO2 to stimulate respiration

    Depressed cardiovascular drive

    Gaseous space enlargement by NO

    Fluoride-ion toxicity from methoxyflurane

    Metabolized in liver = release of Fluoride ions

    Decreased renal function allows fluoride toaccumulate = nephrotoxicity

    Toxicity and Side Effects

  • 8/2/2019 Pharmacology II Dentistry 1

    55/59

    Moderate Sedation

  • 8/2/2019 Pharmacology II Dentistry 1

    56/59

    Dentistry Implications

  • 8/2/2019 Pharmacology II Dentistry 1

    57/59

    Dentistry Implications

  • 8/2/2019 Pharmacology II Dentistry 1

    58/59

    Dentistry Implications

  • 8/2/2019 Pharmacology II Dentistry 1

    59/59

    Dentistry Implications